QUOTE AND NEWS
Marketwire  Apr 24  Comment 
LAVAL, QUEBEC -- (Marketwire) -- 04/24/12 -- Warnex Inc. (TSX VENTURE:WNX) ("Warnex") announces that it has successfully completed the sale of its Analytical Services division to NEOPHARM LABS Inc. ("NEOPHARM"), the previously announced purchaser who
Marketwire  Apr 20  Comment 
LAVAL, QUEBEC -- (Marketwire) -- 04/20/12 -- Warnex Inc. (TSX:WNX) ("Warnex") is pleased to provide the following update regarding its operations. Refinancing of Operations Warnex has completed a new credit facility with Accord Financial Inc.
Marketwire  Apr 16  Comment 
LAVAL, QUEBEC -- (Marketwire) -- 04/16/12 -- Warnex Inc. (TSX:WNX) ("Warnex") announces that Persistence Capital Partners LP ("PCP"), the holder of its outstanding debentures (the "Debentures"), has agreed to extend until April 19, 2012, the date by
Marketwire  Apr 5  Comment 
LAVAL, QUEBEC -- (Marketwire) -- 04/05/12 -- Warnex Inc. (TSX:WNX) ("Warnex") announced today financial results for the year ended December 31, 2011. 2011 Highlights -- Sold the assets of its Medical Laboratories division to Gamma-Dynacare Medical
Marketwire  Apr 4  Comment 
LAVAL, QUEBEC -- (Marketwire) -- 04/04/12 -- Warnex Inc. (TSX:WNX) ("Warnex") wishes to provide the following update regarding its operations. Financial Situation Warnex announces that it has reached an agreement with Persistence Capital Partners LP
Marketwire  Mar 28  Comment 
LAVAL, QUEBEC -- (Marketwire) -- 03/28/12 -- Warnex Inc. (TSX:WNX) ("Warnex") announces that it has received a formal notice of default from the holder of its outstanding debentures requiring that the full repayment of all amounts owing there under,
Marketwire  Mar 28  Comment 
LAVAL, QUEBEC -- (Marketwire) -- 03/28/12 -- Warnex Inc. (TSX:WNX) ("Warnex") announces that the public filing of its audited consolidated financial statements for the financial year ended December 31, 2011 and the related Management's Discussion and
Marketwire  Mar 26  Comment 
LAVAL, QUEBEC -- (Marketwire) -- 03/26/12 -- Warnex Inc. (TSX:WNX) ("Warnex") wishes to provide the following update regarding its operations. Strategic Review and Valuation As previously announced in November 2011, Warnex has undertaken a review of
Marketwire  Feb 14  Comment 
LAVAL, QUEBEC -- (Marketwire) -- 02/14/12 -- Warnex Inc. (TSX:WNX) ("Warnex") announces that it is no longer proceeding with the previously announced sale of its Analytical Services division due to the failure of its prospective purchaser to perform
Marketwire  Feb 2  Comment 
LAVAL, QUEBEC -- (Marketwire) -- 02/02/12 -- Warnex Inc. (TSX:WNX) ("Warnex") is pleased to announce that it has reached an agreement with Persistence Capital Partners LP ("PCP") to extend the maturity date of one of its outstanding convertible





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki